Promoter-specific targeting of human SWI-SNF complex by Epstein-Barr virus nuclear Protein 2

Journal of Virology

Volumn 74, Issue 19, 2000, Pages 8893-8903

  Wu, D Y ^a   Krumm, A ^a   Schubach, W H ^a  

^a VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; VIRUS PROTEIN;

ARTICLE; CHROMATIN; EPSTEIN BARR VIRUS; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; QUANTITATIVE ASSAY; VIRUS CELL INTERACTION;

BASE SEQUENCE; CELL TRANSFORMATION, VIRAL; CHROMATIN; GENE EXPRESSION REGULATION, VIRAL; HERPESVIRUS 4, HUMAN; HUMAN; MOLECULAR SEQUENCE DATA; NUCLEAR PROTEINS; SUPPORT, U.S. GOV'T, NON-P.H.S.; SUPPORT, U.S. GOV'T, P.H.S.; VIRAL PROTEINS;

EID: 0033798412     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.74.19.8893-8903.2000     Document Type: Article

References (67)

1. A SWI/SNF-related chromatin remodeling complex, E-RC1, is required for tissue-specific transcriptional regulation by EKLF in vitro
2. Epstein-Barr virus nuclear antigen 3C is a powerful repressor of transcription when tethered to DNA
3. Continuous and widespread roles for Swi-Snf complex in transcription
4. Role of CBP/P300 in nuclear receptor signalling
5. A viral mechanism for inhibiting p300 and PCAF acetyl-transferase activity
6. Two human homologues of Saccharomyces cerevisiae SWI2/SNF2 and Drosophila brahma are transcriptional coactivators cooperating with the estrogen receptor and the retinoic acid receptor
7. A human RNA polymerase II complex containing factors that modify chromatin structure
8. Epstein-Barr virus nuclear protein 2 mutations define essential domains for transformation and transactivation
9. Stable transfection of Epstein-Barr virus (EBV) nuclear antigen 2 in lymphoma cells containing the EBV P3HR1 genome induces the expression of B-cell activation molecules CD21 and CD23
10. Ordered recruitment of transcription and chromatin remodeling factors to a cell cycle- and developmentally regulated promoter
11. An EBNA-1-dependent enhancer acts from a distance of 10 kilobase pairs to increase expression of the Epstein-Barr virus LMP gene
12. Myc-Max heterodimers activate a DEAD box gene and interact with multiple E box-related sites in vivo
13. The Epstein-Barr virus nuclear antigen 2 transactivator is directed to response elements by the J kappa recombination signal binding protein
14. Genetic analysis of immortalizing functions of Epstein-Barr virus in human B lymphocytes
15. Mediation of Epstein-Barr virus EBNA2 transactivation by recombination signal-binding protein J kappa
16. Truncated mammalian Notch1 activates CBF1/RPB Jκ-repressed genes by a mechanism resembling Epstein-Barr virus EBNA2
17. Facilitated binding of TATA-binding protein to nucleosomal DNA
18. Three unrelated viral transforming proteins (vIRF, EBNA2, and E1A) induce the MYC oncogene through the interferon-responsive PRF element by using different transcription coadaptors
19. BRG1 contains a conserved domain of the SWI2/SNF2 family necessary for normal mitotic growth and transcription
20. A C-EBP beta isoform recruits the SWI/SNF complex to activate myeloid genes
21. Promoter-proximal pausing of RNA polymerase II defines a general rate-limiting step after transcription initiation
22. Long-distance transcriptional enhancement by the histone acetyltransferase PCAF
23. Expression of Epstein-Barr virus nuclear antigen-2 (EBNA2) induces CD21/CR2 on B and T cell lines and shedding of soluble CD21
24. Identification and characterization of an Epstein-Barr virus nuclear antigen 2-responsive cis element in the bidirectional promoter region of latent membrane protein and terminal protein 2 genes
25. Targeting a SWI/SNF-related chromatin remodeling complex to the beta-globin promoter in erythroid cells
26. The Epstein-Barr virus determined nuclear antigens EBNA-3A, -3B, and -3C repress EBNA-2-mediated transactivation of the viral terminal protein 1 gene promoter
27. Contribution of conserved amino acids in mediating the interaction between EBNA2 and CBF1/RBP Jκ
28. The immunoglobulin heavy chain locus control region increases histone acetylation along linked c-myc genes
29. A human protein with homology to Saccharomyces cerevisiae SNF5 interacts with the potential helicase hbrm
30. A human homologue of Saccharomyces cerevisiae SNF2/SWI2 and Drosophila brm genes potentiates transcriptional activation by the glucocorticoid receptor
31. The Med proteins of yeast and their function through the RNA polymerase II carboxy-terminal domain
32. Transcriptional activation by Gcn4p involves independent interactions with the SWI/SNF complex and the SRB/mediator
33. Activation domain-mediated targeting of the SWI/SNF complex to promoters stimulates transcription from nucleo-some arrays
34. The transcriptional coactivators p300 and CBP are histone acetyltransferases
35. The mammalian transcriptional repressor RBP (CBF1) targets TFIID and TFIIA to prevent activated transcription
36. Tissue-specific and developmental stage-specific DNA binding by a mammalian SWI/SNF complex associated with human fetal-to-adult globin gene switching
37. Sequence and functional analysis of EBNA-LP and EBNA2 proteins from nonhuman primate lymphocryptoviruses
38. Reconstitution of a core chromatin remodeling complex from SWI/SNF subunits
39. Epstein-Barr virus EBNA3C represses Cp, the major promoter for EBNA expression, but has no effect on the promoter of the cell gene CD21
40. Epstein-Barr virus nuclear antigen 3C interacts with histone deacetylase to repress transcription
41. Sequence-specific positioning of nucleosomes over the steroid-inducible MMTV promoter
42. Epstein-Barr virus nuclear protein 3C modulates transcription through interaction with the sequence-specific DNA-binding protein Jκ
43. The nucleosome remodeling complex, Snf/Swi, is required for the maintenance of transcription in vivo and is partially redundant with histone acetyltransferase GCN5
44. A vector that replicates as a plasmid and can be efficiently selected in B-lymphoblasts transformed by Epstein-Barr virus
45. The activation antigen BLAST-2, when shed, is an autocrine growth BCGF for normal and transformed B-lymphoblasts
46. The 62- and 80-kDa subunits of transcription factor lIH mediate the interaction with Epstein-Barr virus nuclear protein 2
47. The Epstein-Barr virus nuclear protein 2 acidic domain can interact with TFIIB, TAF40, and RPA70 but not with TATA-binding protein
48. Recruitment of the SWI-SNF chromatin remodeling complex as a mechanism of gene activation by the glucocorticoid receptor τ1 activation domain
49. The human J kappa recombination signal sequence binding protein (RBP-J kappa) targets the Epstein-Barr virus EBNA2 protein to its DNA responsive elements
50. Epstein-Barr virus EBNA3A and EBNA3C proteins both repress RBP-Jκ-EBNA2-activated transcription by inhibiting the binding of RBP-Jκ to DNA
51. Epstein-Barr virus nuclear protein 2 transactivates a cis-acting CD23 DNA element
52. Epstein-Barr virus nuclear antigen 2 transactivates latent membrane protein LMP1
53. Epstein-Barr virus nuclear protein 2 interacts with p300, CBP, and PCAF histone acetyltransferases in activation of LMP1 promoter
54. Purification and biochemical heterogeneity of the mammalian SWI-SNF complex
55. Diversity and specialization of mammalian SWI/SNF complexes
56. RNA polymerase II holoenzyme contains SWI/SNF regulators involved in chromatin remodeling
57. Yeast SNF-SWI transcriptional activators and the SPT/SIN chromatin connection
58. Alteration of nucleosome structure as a mechanism of transcriptional regulation
59. The 5' end of Drosophila heat shock genes in chromatin are hypersensitive to DNAse I
60. Epstein-Barr virus nuclear protein 2 (EBNA2) binds to a component of the human SNF-SWI complex, hSNF5/Inil
61. Evidence that Snf-Swi controls chromatin structure over both the TATA and UAS regions of the SUC2 promoter in Saccharomyces cerevisiae
62. Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells
63. Roles of SWI1, SWI2, and SWI3 proteins for transcriptional enhancement by steroid receptors
64. Recruitment of the SWI/SNF chromatin remodeling complex by transcriptional activators
65. Epstein-Barr virus nuclear antigen 2 exerts its transactivating function through interaction with recombination signal binding protein RBP-J kappa, the homologue of Drosophila Suppressor of Hairless
66. Epstein-Barr virus nuclear antigen 2 activates transcription of the terminal protein gene
67. A role for SKIP in EBNA2 activation of CBF1-repressed promoters